LON:HLN Haleon (HLN) Share Price, News & Analysis GBX 355.20 +2.20 (+0.62%) As of 08/8/2025 11:57 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Haleon Stock (LON:HLN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Haleon alerts:Sign Up Key Stats Today's Range 353.50▼ 356.2050-Day Range 348.10▼ 416.5652-Week Range 346.10▼ 419.50Volume17.22 million shsAverage Volume25.31 million shsMarket Capitalization£32.06 billionP/E Ratio29.87Dividend Yield1.69%Price TargetGBX 413.50Consensus RatingHold Company Overview Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding. Read More Haleon Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreHLN MarketRank™: Haleon scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingHold Consensus RatingHaleon has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageHaleon has only been the subject of 2 research reports in the past 90 days.Read more about Haleon's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Haleon is 29.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 27.92.Price to Earnings Ratio vs. SectorThe P/E ratio of Haleon is 29.87, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.98.Price to Earnings Growth RatioHaleon has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 1.95. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for HLN. Dividend0.8 / 5Dividend StrengthWeak Dividend YieldHaleon has a dividend yield of 0.02%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Haleon is 50.46%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Haleon's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for HLN. News and Social Media2.5 / 5News Sentiment0.52 News SentimentHaleon has a news sentiment score of 0.52. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Haleon this week, compared to 1 article on an average week.Search Interest3 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership3.3 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have sold 183.95% more of their company's stock than they have bought. Specifically, they have bought £111,090.80 in company stock and sold £315,441.44 in company stock.Percentage Held by Insiders10.74% of the stock of Haleon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions43.88% of the stock of Haleon is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Haleon's insider trading history. Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Email Address HLN Stock News HeadlinesHaleon plc (NYSE:HLN) Q2 2025 Earnings Call TranscriptAugust 6 at 9:32 AM | insidermonkey.comHaleon's (HLN) "Underweight" Rating Reiterated at JPMorgan Chase & Co.August 4, 2025 | americanbankingnews.comMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.August 9 at 2:00 AM | Brownstone Research (Ad)Haleon (LON:HLN) Has Announced A Dividend Of £0.022August 3, 2025 | finance.yahoo.comHaleon's (HLN) "Sector perform" Rating Reiterated at Royal Bank Of CanadaAugust 3, 2025 | americanbankingnews.comHaleon slides Thursday, underperforms marketJuly 31, 2025 | marketwatch.comHaleon trims organic revenue growth outlook amid NA weakness; stock slipsJuly 31, 2025 | investing.comHaleon Shares Fall on Cut to Organic Revenue GuidanceJuly 31, 2025 | msn.comSee More Headlines HLN Stock Analysis - Frequently Asked Questions How have HLN shares performed this year? Haleon's stock was trading at GBX 377.40 at the beginning of the year. Since then, HLN stock has decreased by 5.9% and is now trading at GBX 355.20. How were Haleon's earnings last quarter? Haleon plc (LON:HLN) posted its earnings results on Thursday, July, 31st. The company reported $8.90 earnings per share (EPS) for the quarter. Haleon had a net margin of 9.66% and a trailing twelve-month return on equity of 6.54%. How do I buy shares of Haleon? Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Haleon own? Based on aggregate information from My MarketBeat watchlists, some other companies that Haleon investors own include GSK (GSK), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Meta Platforms (META) and Unilever (ULVR). Company Calendar Record date for 6/5 Dividend4/24/2025Ex-Dividend for 6/5 Dividend4/24/2025Dividend Payable6/05/2025Last Earnings7/31/2025Today8/09/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryConsumer Goods Current SymbolLON:HLN CIKN/A Webwww.haleon.com Phone44 1932 822000FaxN/AEmployees25,408Year FoundedN/APrice Target and Rating Average Price Target for HaleonGBX 413.50 High Price TargetGBX 457 Low Price TargetGBX 370 Potential Upside/Downside+16.4%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)GBX 11.89 Trailing P/E Ratio29.87 Forward P/E Ratio18.21 P/E Growth1.49Net Income£1.07 billion Net Margins9.66% Pretax MarginN/A Return on Equity6.54% Return on Assets4.45% Debt Debt-to-Equity Ratio53.36 Current Ratio0.84 Quick Ratio0.93 Sales & Book Value Annual Sales£11.07 billion Price / Sales2.90 Cash FlowGBX 16.18 per share Price / Cash Flow21.95 Book ValueGBX 182.02 per share Price / Book1.95Miscellaneous Outstanding Shares9,025,597,051Free FloatN/AMarket Cap£32.06 billion OptionableNot Optionable Beta0.19 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (LON:HLN) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Haleon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.